SCHEMBL6609569

SCHEMBL6609569

CN(Cc1ccccc1)C(=O)CCCC(=O)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.70
RAB9A P51151 4/20 0.70
KMT2A Q03164 3/20 0.64
TDP1 Q9NUW8 2/20 0.56
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
L3MBTL1 Q9Y468 3/20 0.54
MEN1 O00255 1/20 0.54
LMNA P02545 1/20 0.53
MAPT P10636 1/20 0.53
CA12 O43570 1/20 0.51
CA9 Q16790 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
BCHE P06276 1/20 0.51
ACHE P22303 1/20 0.51
ALDH1A1 P00352 1/20 0.49
POLB P06746 1/20 0.49
RIPK1 Q13546 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4072151 0.90 NPC1 (0.85) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL4074355 0.85 NPC1 (0.77) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL5110210 0.83 NPC1 (0.72) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL16831598 0.82 NPC1 (0.77) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL415549 0.81 RAB9A (0.74) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL8017184 0.79 NPC1 (0.72) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL4495709 0.79 KMT2A (0.69) NPC1RAB9AKMT2AL3MBTL1MEN1
SCHEMBL4593680 0.79 KMT2A (0.62) NPC1RAB9AKMT2ATDP1CASP3
SCHEMBL7761239 0.79 NPC1 (0.72) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL14946877 0.79 NPC1 (0.72) NPC1RAB9AKMT2AMEN1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142887-B1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE DAVIS & CO (US) 2004-04-07 EP disclosed
EP-0729463-B1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2002-05-22 EP disclosed
EP-1142887-A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE, DAVIS & COMPANY (US) 2001-10-10 EP disclosed
US-5936128-A BENZENETHIOL COMPOUNDS AS INTERMEDIATES; BACTERICIDES, VIRICIDES; HIV WARNER-LAMBERT COMPANY (US) 1999-08-10 US disclosed
US-5840751-A ADMINISTERING IN THE TREATMENT OF INFECTION OR DISEASE CAUSED BY A RETROVIRUS WARNER-LAMBERT COMPANY (US) 1998-11-24 US disclosed
US-5789440-A 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents WARNER-LAMBERT COMPANY (US) 1998-08-04 US disclosed
EP-0729463-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729464-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014012-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014011-A2 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed